𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biologic therapies for the treatment of rheumatoid arthritis

Book ID
108711334
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
398 KB
Volume
35
Category
Article
ISSN
0014-2972

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Emerging therapies in the treatment of r
Emerging therapies in the treatment of rheumatoid arthritis
✍ Jinqi Liu; Huseyin Mehmet πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 1 views

## Abstract Rheumatoid arthritis (RA) is an autoimmune disease with a significant morbidity defined by marked destruction and deformity of joints. It is characterized by autoantibody production, synovial inflammation, and erosion of the cartilage and bone. The current first‐line treatment for RA is

New therapies for rheumatoid arthritis
New therapies for rheumatoid arthritis
✍ F. Goldblatt; D. A. Isenberg πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 161 KB
Compliance with biologic therapies for r
Compliance with biologic therapies for rheumatoid arthritis: Do patient out-of-pocket payments matter?
✍ Curkendall, S. ;Patel, V. ;Gleeson, M. ;Campbell, R. S. ;Zagari, M. ;Dubois, R. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 2 views

## Abstract ## Objective To assess the impact of patient out‐of‐pocket (OOP) expenditures on adherence and persistence with biologics in patients with rheumatoid arthritis (RA). ## Methods An inception cohort of RA patients with pharmacy claims for etanercept or adalimumab during 2002–2004 was s